HomeGreater Than Icon
Kronox Lab Sciences LtdGreater Than Icon
Kronox Lab Sciences Ltd Financials
Company Logo

Kronox Lab Sciences Ltd Financial Statement

Kronox Lab Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue25.62
Operating Expense16.98
Net Profit6.15
Net Profit Margin24.00
Earning Per Share1.67
EBIDTA8.65
Effective Tax Rate25.12

Kronox Lab Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual89.86
Operating Expenses Annual61.54
Operating Profit Annual29.90
Interest AnnualTBA
Depreciation1.25
Net Profit Annual21.35
Tax Annual7.26

Kronox Lab Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning2.48
Cash Flow from Operations17.42
Cash Flow from Investing-17.31
Cash Flow from FinancingTBA
Cash Flow at the End2.59

Kronox Lab Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)33.27
PBIT Margin (%)31.84
PBT Margin (%)31.84
Net PROFIT Margin (%)23.76
Return On Networth / Equity (%)38.45
Return On Networth /Employed (%)51.29
Return On Assets (%)38.25
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)1.61

Kronox Lab Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual26.41
Total Current Assets Annual46.60
Non Current Assets Annual27.40
Total Shareholders Funds Annual66.31
Total Assets Annual73.99

Kronox Lab Sciences Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, Kronox Lab Sciences Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
Yes, Kronox Lab Sciences Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Kronox Lab Sciences Ltd recorded a total revenue of approximately 89.86 Cr marking a significant milestone in the company's financial performance.
Kronox Lab Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.0% annually, respectively..
Kronox Lab Sciences Ltd's current PE ratio is undefined.
Kronox Lab Sciences Ltd's ROCE averaged 45.2% from the FY ending March 2022 to 2024, with a median of 43.1%. It peaked at 49.5% in March 2023, reflecting strong capital efficiency over the period..
Kronox Lab Sciences Ltd's latest EBIT is Rs. 28.61 Cr, surpassing the average EBIT of Rs. 23.17 Cr over the 5 years..